DWA
ELAN icon

Dorsey Wright & Associates’s Elanco Animal Health ELAN Stock Holding History

Dorsey Wright & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Sell
267,680
-205,134
-43% -$4.74M 1.12% 33
2026
Q1 		$11.3M Buy
+472,814
New +$11.6M 1.4% 22

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Dorsey Wright & Associates's ELAN Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its Elanco Animal Health (ELAN) stake by 43% in Q2 2026, selling an estimated $4.74M and leaving 267,680 shares worth $6.59M. The position accounts for 1.12% of the portfolio, ranked #33.

Dorsey Wright & Associates first reported a position in ELAN in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.3M in Q1 2026. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Dorsey Wright & Associates held 267,680 shares of Elanco Animal Health worth $6.59M as of Q2 2026.
  • Dorsey Wright & Associates sold 205,134 Elanco Animal Health shares in Q2 2026, an estimated $4.74M.
  • Elanco Animal Health made up 1.12% of Dorsey Wright & Associates's portfolio in Q2 2026, its #33 holding.
  • Dorsey Wright & Associates first reported a position in Elanco Animal Health in Q1 2026 and has held it in 2 quarters since.
  • Dorsey Wright & Associates's Elanco Animal Health position peaked at $11.3M in Q1 2026.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.